Five pharmaceutical companies said on Friday they have filed a complaint in a Canadian court challenging the constitutionality of new Canadian regulations meant to lower patented drug prices, setting up a fight with the federal government ahead of an Oct. 21 e…

(Reuters Health) - Family caregivers for dementia patients don't sleep as long or as well as other adults of the same age, a new study suggests.

(Reuters Health) - Even though American veterans are at high risk for the type of hearing loss that may be improved with cochlear implants, many of them live hours from a VA facility that provides cochlear implant services, a U.S. study suggests.

The U.S. Centers for Disease Control and Prevention said on Friday it had identified 193 potential cases of severe lung illness tied to vaping in 22 states as of Aug. 22, including one adult in Illinois who died after being hospitalized.

(Reuters Health) - As legal cannabis use becomes increasingly common in the U.S., most parents say they keep their pot out of children's reach, but fewer keep it locked away, a study in Colorado suggests.

Democratic U.S. presidential candidate Pete Buttigieg aims to prevent one million deaths by 2028 from addiction and mental illness under a plan he released on Friday aimed at tackling the country's opioid and substance abuse crisis.

(Reuters Health) - Women with type 2 diabetes may face more sleep issues and more severe sleep troubles during menopause than peers without diabetes, a small study suggests.

Ebola appears to be under control in the city of Goma in Congo but it has flared in other parts of the country, where aid workers are combating insecurity and disinformation on social media, the World Health Organization (WHO) said on Friday.

A proposed move to universal health coverage in South Africa will be rolled out in stages as the budget improves, a senior presidential aide told Reuters, forecasting the landmark reform would cost $2.2 billion per year by 2025/26.

LONDON, Aug 23 - Eradicating malaria is biologically feasible and a lofty aim, the World Health Organization said on Friday, but the focus for now should be getting the funds, tools and political will to control it.

GlaxoSmithKline said an experimental multiple myeloma treatment has shown a meaningful response in patients that have run out of three previous treatment options, in a boost for the British drugmaker's cancer drug business.